Loading chat...
IN SB0237
Bill
AI Summary
-
Classifies any material, compound, mixture, or preparation containing ephedrine or pseudoephedrine as Schedule III controlled substances requiring prescription for dispensing, effective July 1, 2016.
-
Repeals the previous statute allowing over-the-counter sales of ephedrine and pseudoephedrine without prescription, along with related definitions and provisions in Indiana Code.
-
Requires pharmacies and NPLEx retailers that maintained sales logs before July 1, 2016 to continue preserving those electronic or written logs through June 30, 2018, with access provided to law enforcement and the criminal justice institute.
-
Amends controlled substance possession statutes to reflect that ephedrine and pseudoephedrine are now Schedule III substances subject to prescription requirements and standard possession penalties.
Legislative Description
Pseudoephedrine and ephedrine. Provides that materials, compounds, mixtures, or preparations that contain ephedrine or pseudoephedrine are schedule III controlled substances that may be dispensed only by prescription. Repeals: (1) the statute allowing the dispensing of ephedrine and pseudoephedrine without a prescription subject to certain restrictions; and (2) provisions related to that statute. Requires pharmacies and certain retailers that sell ephedrine, pseudoephedrine, or drugs that contain ephedrine or pseudoephedrine before July 1, 2016, to continue to maintain an electronic or written log of such sales through June 30, 2018.
Last Action
Pursuant to Senate Rule 68(b); reassigned to Committee on Corrections & Criminal Law
1/11/2016